Breaking News Instant updates and real-time market news.

NKTR

Nektar

$71.59

1.43 (2.04%)

08:21
01/22/18
01/22
08:21
01/22/18
08:21

Nektar price target raised to $89 from $45 at Mizuho

Mizuho analyst Difei Yang raised her price target for Nektar Therapeutics to $89 citing the "impressive" safety and efficacy data observed so far in clinical trials for NKTR-214. The drugmaker closed Friday up $1.43 to $71.59. There is a "good chance" the upcoming data readouts at the American Society of Clinical Oncology in June will be positive, which could provide "strong upside for the shares," Yang tells investors in a research note. The analyst believes NKTR-214 has been impressive across all cancer types and is "ahead of the competition." She believes the drug has the potential to work across many indications and points out the asset is wholly-owned by Nektar. From a potential acquirer's perspective, a wholly-owned asset is more attractive, Yang contends. She reiterates a Buy rating on Nektar.

  • 26

    Feb

NKTR Nektar
$71.59

1.43 (2.04%)

11/13/17
JPMS
11/13/17
NO CHANGE
Target $44
JPMS
Overweight
Nektar price target raised to $44 from $27 at JPMorgan
JPMorgan analyst Jessica Fye raised her price target for Nektar Therapeutics to $44 saying she views the company's STIC data as a "win" given the "encouraging response rates" in both PD-L1 positive and negative patients. The analyst sees increased potential for Nektar to access the large lung market and raised her probability of success to 45% and peak sales for NKTR-214 to $4B. Fye keeps an Overweight rating on Nektar.
11/13/17
ADAM
11/13/17
NO CHANGE
Target $50
ADAM
Buy
Nektar price target raised to $50 from $35 at Canaccord
Canaccord analyst Arlinda Lee raised her price target on Nektar to $50 from $35 following its Phase 1 PIVOT-2 results, which showed its own drug in combination with Opdivo had a promising immuno-oncology effect. She continues to view Nektar's immunology and oncology pipeline as attractive. Lee reiterated her Buy rating on Nektar shares.
01/10/18
ADAM
01/10/18
NO CHANGE
Target $80
ADAM
Buy
Nektar price target raised to $80 after NKTR-214 update at Canaccord
Canaccord analyst Arlinda Lee raised her price target on Nektar Therapeutics to $80 from $50 after the company provided an update on the full Phase 1 PIVOT-2 dose-escalation results that were previously presented at a cancer meeting in November. Lee, who views the update as solidifying the central positioning for NKTR-214, increased her probability of success for the drug candidate in a number of potential indications following the new data. The analyst expects meaningful clinical data presentations for the NKTR-214-Opdivo combo this year, including at the ASCO meeting in June, she added. Lee maintains a Buy rating on Nektar shares, which advanced about 18% yesterday and are up a further 3% this morning.
01/16/18
JEFF
01/16/18
NO CHANGE
Target $88
JEFF
Buy
Nektar price target raised to $88 from $35 at Jefferies
Jefferies analyst David Steinberg raised his price target for Nektar Therapeutics to $88 after adding NKTR-214 to his model. The shares closed Friday up 3%, or $2.12, to $72.00. Mounting evidence beyond "proof of concept" suggest NKTR-214 could emerge as a "significant new cancer agent," Steinberg tells investors in a research note. The analyst models for three indications that Nektar could self-market, although he believes "there could be many more." Steinberg keeps a Buy rating on shares of Nektar.

TODAY'S FREE FLY STORIES

TRVG

Trivago

$4.71

-1.65 (-25.94%)

05:01
04/26/18
04/26
05:01
04/26/18
05:01
Downgrade
Trivago rating change  »

Trivago downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPR

HighPoint Resources

$6.65

0.14 (2.15%)

04:58
04/26/18
04/26
04:58
04/26/18
04:58
Initiation
HighPoint Resources initiated  »

HighPoint Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

AVY

Avery Dennison

$106.68

1.195 (1.13%)

04:57
04/26/18
04/26
04:57
04/26/18
04:57
Upgrade
Avery Dennison rating change  »

Avery Dennison upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Jobless Claims to be reported at 08:30 »

Week of 4/21 Jobless…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

Week of 4/25 Fed Balance…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Durable Goods Orders to be reported at 08:30 »

March Durable Goods…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Durable Goods Orders Ex-transportation to be reported at 08:30 »

March Durable Goods…

WYN

Wyndham

$117.67

1.83 (1.58%)

, LQ

La Quinta

$19.70

0.08 (0.41%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
La Quinta to host special shareholder meeting »

Special Shareholder…

WYN

Wyndham

$117.67

1.83 (1.58%)

LQ

La Quinta

$19.70

0.08 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 02

    May

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

6-Month Bill Announcement…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

Week of 4/16 Money Supply…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
International Trade in Goods Balance to be reported at 08:30 »

March International Trade…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Wholesale Inventories [Advance] M/M % hange to be reported at 08:30 »

March Wholesale…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

Week of 4/20 EIA Natural…

SMMT

Summit Therapeutics

$13.66

0.13 (0.96%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
Summit Therapeutics management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

ABBV

AbbVie

$91.91

0.57 (0.62%)

, ACOR

Acorda Therapeutics

$22.95

-0.15 (-0.65%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
American Academy of Neurology to hold annual meeting »

2018 Annual Meeting of…

ABBV

AbbVie

$91.91

0.57 (0.62%)

ACOR

Acorda Therapeutics

$22.95

-0.15 (-0.65%)

ALXN

Alexion

$106.07

-0.37 (-0.35%)

AKCA

Akcea Therapeutics

$26.85

0.02 (0.07%)

RHHBY

Roche

TEVA

Teva

$17.27

-0.28 (-1.60%)

UBS

UBS

$16.78

-0.095 (-0.56%)

MDT

Medtronic

$79.47

0.12 (0.15%)

MCK

McKesson

$151.70

2.76 (1.85%)

NVTA

Invitae

$5.53

-0.15 (-2.64%)

IONS

Ionis Pharmaceuticals

$43.98

-1.35 (-2.98%)

IPXL

Impax

$19.25

-0.65 (-3.27%)

DNA

Bought by RHHBY

DGX

Quest Diagnostics

$101.17

1.42 (1.42%)

ESALY

Eisai

DEPO

Depomed

$6.66

-0.17 (-2.49%)

CPRX

Catalyst Pharmaceuticals

$2.64

0.04 (1.54%)

BSX

Boston Scientific

$29.44

1.01 (3.55%)

BMRN

BioMarin

$81.41

0.33 (0.41%)

MYL

Mylan

$38.93

-1.32 (-3.28%)

NBIX

Neurocrine

$78.13

-0.3 (-0.38%)

NVS

Novartis

$76.42

-0.58 (-0.75%)

PFE

Pfizer

$36.69

-0.36 (-0.97%)

RARX

RA Pharmaceuticals

$5.76

-0.2 (-3.36%)

SNY

Sanofi

$40.11

0.335 (0.84%)

SYK

Stryker

$165.44

0.77 (0.47%)

SUPN

Supernus

$47.30

0.55 (1.18%)

LLY

Eli Lilly

$81.17

1.08 (1.35%)

BAYRY

Bayer

AMGN

Amgen

$174.83

2.92 (1.70%)

ALNY

Alnylam

$94.35

-0.34 (-0.36%)

BIIB

Biogen

$269.47

7.45 (2.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 27

    Apr

  • 28

    Apr

  • 30

    Apr

  • 30

    Apr

  • 01

    May

  • 02

    May

  • 02

    May

  • 03

    May

  • 04

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 10

    May

  • 17

    May

  • 18

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 23

    May

  • 23

    May

  • 25

    May

  • 28

    May

  • 30

    May

  • 05

    Jun

  • 07

    Jun

  • 07

    Jun

  • 12

    Jun

  • 12

    Jun

  • 16

    Jun

  • 06

    Jul

  • 11

    Aug

  • 12

    Sep

  • 05

    Oct

  • 20

    Oct

  • 13

    Nov

  • 28

    Jan

SCPH

scPharmaceuticals

$9.92

-0.1 (-1.00%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
scPharmaceuticals management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 23

    Jun

ALNA

Allena Pharmaceuticals

$14.77

0.845 (6.07%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
Allena Pharmaceuticals management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

RIO

Rio Tinto

$55.24

-0.44 (-0.79%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
Rio Tinto management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

Week of 4/22 Bloomberg…

SPNE

SeaSpine

$11.05

-0.11 (-0.99%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
SeaSpine management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

  • 03

    May

PYPL

PayPal

$74.00

-1.29 (-1.71%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
PayPal has a conference call hosted by JPMorgan »

JPMorgan Analyst Huang…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 22

    May

  • 23

    May

  • 12

    Jun

NFLX

Netflix

$305.73

-1.51 (-0.49%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
Netflix management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

3-Month Bill Announcement…

ADOM

Adomani

$0.71

-0.0401 (-5.35%)

, AEYE

AudioEye

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
SNN to hold a conference »

Planet MicroCap Showcase…

ADOM

Adomani

$0.71

-0.0401 (-5.35%)

AEYE

AudioEye

AMBS

Amarantus Bioscience

AZRX

AzurRx BioPharma

$2.66

-0.23 (-7.96%)

CTHR

Charles & Colvard

$1.36

0.01 (0.74%)

DPW

DPW Holdings

$0.97

-0.0476 (-4.67%)

GMRE

Global Medical REIT

$7.81

-0.26 (-3.22%)

ISDR

Issuer Direct Corp.

$16.00

0.2 (1.27%)

ISR

IsoRay

$0.45

0.0046 (1.03%)

MNGA

Magnegas

$0.74

-0.0191 (-2.51%)

NEWT

Newtek Business Services

$17.78

-0.05 (-0.28%)

OMN

Omnova Solutions

$11.35

0.05 (0.44%)

PBIO

Pressure BioSciences

PFIE

Profire Energy

$3.94

0.27 (7.36%)

SGLB

Sigma Labs

$1.14

-0.02 (-1.72%)

SNYR

Synergy Strips

SRAX

Social Reality

$4.62

0.15 (3.36%)

SSFT

ScanSoft

VNRX

VolitionRx

$2.12

0.02 (0.95%)

XPLR

Xplore Technologies

$3.32

-0.04 (-1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 02

    May

  • 03

    May

  • 08

    May

  • 09

    May

  • 23

    May

  • 01

    Jun

  • 07

    Jun

PKOH

Park-Ohio

$37.50

-0.35 (-0.92%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
Park-Ohio management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.